Medesis Pharma SA Cash Flow Reinvestment Rate
Medesis Pharma SA cash flow reinvestment rate. Medesis Pharma SA (ALMDP) has a Cash Flow Reinvestment Rate of 0.00x as of December 2020, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €185.83K. Explore Medesis Pharma SA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Medesis Pharma SA (2019–2020)
Cash flow reinvestment rate of Medesis Pharma SA from 2019 to 2020. Historical reinvestment intensity for Medesis Pharma SA across 2 annual periods. Also explore net asset momentum of Medesis Pharma SA to track the company's year-over-year net asset growth rate.
Medesis Pharma SA Cash Flow Reinvestment Rate by Year (2019–2020)
Medesis Pharma SA cash flow reinvestment rate by year from 2019 to 2020. Year-by-year capital reinvestment analysis for Medesis Pharma SA. For the full cash flow conversion analysis, see how efficiently does Medesis Pharma SA generate cash.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.00x | €0.00 | €185.83K | €0.00 | — |
| 2019 | 0.00x | €0.00 | €333.76K | €0.00 | — |